ACTIVE

NOVADIP BIOSCIENCES

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result
-13,1 M €
-398,7 %over 1 year
Gross margin
1,6 M €
-26,2 %over 1 year
Equity
50 M €
-24,9 %over 1 year
Workforce
39,3 ETP
-13,8 %over 1 year

Identity

Source · BCE/KBO

NOVADIP BIOSCIENCES is a Public limited company incorporated in 2013. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Mont-Saint-Guibert. It employs on average 39,3 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0535.575.602
Incorporation
31/05/2013
Legal form
Public limited company
Registered office
Rue Granbonpré 11
1435 Mont-Saint-Guibert · WallonieSee on map
Contributed capital
66 325 354,88 €
Latest accounts
31/12/2025
Average workforce
39,3 ETP
Joint committees (2)
  • 207
  • 2070
Signals
Solid equityPositive cashflowHealthy social debts

Financials

Source · NBB, 15 filings

Trend over 13 financial years

20252024202320222021
Income statement
Gross margin1,6 M €2,2 M €––2,5 M €
EBITDA-2 M €-2,5 M €-2,1 M €-1,8 M €-789,3 k €
Operating result-19,5 M €-2,8 M €-2,5 M €-2,3 M €-1,2 M €
Net result-13,1 M €-2,6 M €-1,9 M €-2,3 M €-1,4 M €
Balance sheet
Equity50 M €66,6 M €66,2 M €65,1 M €51,8 M €
Total assets85,3 M €91,5 M €80,3 M €72,7 M €61,4 M €
Cash877,9 k €364,7 k €665,7 k €3,3 M €10,3 M €
Debts34 M €24,7 M €14 M €7,5 M €9,6 M €
Other
Workforce39,3 ETP45,6 ETP39,5 ETP37,8 ETP39,3 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

9 active · 46 ended

Active mandates

Drew Trivisonno

Director · since 21 novembre 2024 · until 11 mai 2027

Active
Patrick Van Beneden

Director · since 16 novembre 2023 · until 11 mai 2027

Active
AXXIS V EN C

Director · since 20 octobre 2021 · until 11 mai 2027 · 0464.259.123

Represented by Gil BEYEN

Active
Eric Pâques

Director · since 20 octobre 2021 · until 11 mai 2027

Active
Jean-Pierre Bizet

Director · since 20 octobre 2021 · until 11 mai 2027

Active
SPARAXIS

Director · since 20 octobre 2021 · until 11 mai 2027 · 0452.116.307

Represented by Christine Franssen

Active
Theracell Consulting

Managing director · since 20 octobre 2021 · until 11 mai 2027 · 0535.788.408

Represented by Denis DUFRANE

Active
VIVES II - Louvain Technology Fund

Director · since 20 octobre 2021 · until 11 mai 2027 · 0838.819.178

Represented by Philippe DURIEUX

Active
Da Liu

Director

Active

Ended mandates

VIVES PARTNERS

Director · since 12 février 2024 · until 11 mai 2027 · 1004.227.835

Represented by Philippe DURIEUX

Ended
AXXIS V EN C

Director · since 20 octobre 2021 · until 11 mai 2027 · 0464.259.123

Represented by Gil Beyen

Ended
Philippe Monteyne

Director · since 20 octobre 2021 · until 11 mai 2027

Ended
Philippe MONTEYNE

Director · since 20 octobre 2021 · until 16 novembre 2023

Ended

Other companies at this address

Rue Granbonpré 11 1435 Mont-Saint-Guibert
CompanyCBE no.
Ascend Performance Materials● Active
0810.113.316
Ascend Performance Materials Belgium Holdco● Active
1012.379.397
AUDANE INVEST● Active
0816.921.429
BiocSol● Active
1003.683.546
CEDRIC CLAERHOUDT● Active
0477.799.927
Cellaïon● Liquidation
0764.522.425
Clinigen Clinical Supplies Management● Active
0859.906.087
Cronos Sud● Active
1014.190.824
DE SMET AGRO● Active
0402.951.757
DE SMET S.A. - ENGINEERS & CONTRACTORS● Active
0438.987.752
FLEXSO BRUSSELS● Active
0898.889.892
Keiro● Active
0681.490.821
PARLYM BELGIUM● Active
1028.144.372
PARSMET MANAGEMENT● Active
1025.167.858
PROMETHERA BIOSCIENCES● Bankrupt
0809.788.365
TFP IMMO● Active
1032.940.330
The Akkermansia Company● Active
0664.529.083
THE TORREFACTORY PROJECT● Active
0679.686.720
Tools4Patient● Active
0534.842.954
VAT Group Ascend● Active
1002.911.308

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelFull modelFull modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date14/07/202610/07/202505/06/202408/06/202325/01/202327/05/2021
General meeting30/06/202617/06/202514/05/202409/05/202310/05/202211/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 15 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202530/06/202614/07/2026FrenchPDF
Abridged model31/12/202417/06/202510/07/2025FrenchPDF
Full model31/12/202314/05/202405/06/2024FrenchPDF
Full model31/12/202209/05/202308/06/2023FrenchPDF
Abridged modelCorrection31/12/202110/05/202225/01/2023FrenchPDF
Abridged modelCorrection31/12/202110/05/202212/10/2022FrenchPDF
Abridged model31/12/202110/05/202216/05/2022FrenchPDF
Abridged model31/12/202011/05/202127/05/2021FrenchPDF
Abridged model31/12/201912/05/202002/06/2020FrenchPDF
Abridged model31/12/201814/05/201905/06/2019FrenchPDF
Abridged model31/12/201708/05/201808/06/2018FrenchPDF
Abridged model31/12/201609/05/201724/05/2017FrenchPDF
Abridged model31/12/201510/05/201612/05/2016FrenchPDF
Abridged model31/12/201411/06/201511/06/2015FrenchPDF
Abridged model31/12/201314/05/201425/08/2014FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

9 active · 46 ended

Active mandates

Drew Trivisonno

Director · since 21 novembre 2024 · until 11 mai 2027

Active
Patrick Van Beneden

Director · since 16 novembre 2023 · until 11 mai 2027

Active
AXXIS V EN C

Director · since 20 octobre 2021 · until 11 mai 2027 · 0464.259.123

Represented by Gil BEYEN

Active
Eric Pâques

Director · since 20 octobre 2021 · until 11 mai 2027

Active
Jean-Pierre Bizet

Director · since 20 octobre 2021 · until 11 mai 2027

Active
SPARAXIS

Director · since 20 octobre 2021 · until 11 mai 2027 · 0452.116.307

Represented by Christine Franssen

Active
Theracell Consulting

Managing director · since 20 octobre 2021 · until 11 mai 2027 · 0535.788.408

Represented by Denis DUFRANE

Active
VIVES II - Louvain Technology Fund

Director · since 20 octobre 2021 · until 11 mai 2027 · 0838.819.178

Represented by Philippe DURIEUX

Active
Da Liu

Director

Active

Ended mandates

VIVES PARTNERS

Director · since 12 février 2024 · until 11 mai 2027 · 1004.227.835

Represented by Philippe DURIEUX

Ended
AXXIS V EN C

Director · since 20 octobre 2021 · until 11 mai 2027 · 0464.259.123

Represented by Gil Beyen

Ended
Philippe Monteyne

Director · since 20 octobre 2021 · until 11 mai 2027

Ended
Philippe MONTEYNE

Director · since 20 octobre 2021 · until 16 novembre 2023

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates07/09/2026
    Démission et nomination d'un administrateur, du commissaire et
    PDF
  • Mandates06/05/2026
    DEMISSIONS, NOMINATIONS
    PDF
  • Other09/01/2024
    DIVERS
    PDF
  • Capital / shares04/08/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Mandates28/11/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares10/10/2022
    CAPITAL, ACTIONS
    PDF
  • Capital / shares24/05/2022
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Capital / shares23/02/2022
    CAPITAL, ACTIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-13,1 M €↓
  2. 15/09/2025
    nominationNovel Ventures Limited — administrateur
  3. 17/06/2025
    reconductionDeloitte Réviseurs d’Entreprises SRL — commissaire
  4. 2024
    Annual accounts 2024-2,6 M €↓
  5. 21/11/2024
    nominationDrew Trivisonno — administrateur
  6. 14/05/2024
    nominationPatrick Van Beneden — administrateur
  7. 12/02/2024
    nominationVIVES Partners SRL — administrateur
  8. 2023
    Annual accounts 2023-1,9 M €↑
  9. 28/07/2023
    augmentation_capital
  10. 2022
    Annual accounts 2022-2,3 M €↓
  11. 29/09/2022
    augmentation_capital
  12. 10/05/2022
    nominationJulie Delforge — commissaire
  13. 10/05/2022
    augmentation_capital
  14. 2021
    Annual accounts 2021-1,4 M €↓
  15. 20/10/2021
    nominationYi Zhou — administrateur
  16. 20/10/2021
    reconductionJean Pierre Bizet — administrateur
  17. 20/10/2021
    reconductionPhilippe Monteyne — administrateur
  18. 20/10/2021
    reconductionSPARAXIS — administrateur
  19. 20/10/2021
    reconductionSOPARTEC — administrateur
  20. 20/10/2021
    reconductionEric Pâques — administrateur indépendant
  21. 20/10/2021
    reconductionAxxis V&C — administrateur
  22. 20/10/2021
    reconductionTheracell Consulting — administrateur
  23. 2020
    Annual accounts 2020-1,3 M €↑
  24. 2019
    Annual accounts 2019-2,3 M €↓
  25. 2018
    Annual accounts 2018-1,9 M €↓
  26. 2017
    Annual accounts 2017-1,2 M €↓
  27. 2016
    Annual accounts 2016-1,2 M €↓
  28. 2015
    Annual accounts 2015-973,3 k €↓
  29. 2014
    Annual accounts 2014-26,7 k €↑
  30. 2013
    Annual accounts 2013-155,8 k €
  31. 31/05/2013
    IncorporationPublic limited company